A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases
Conditions
Interventions
- COMBINATION_PRODUCT: SHR-A1811 and radiotherapy
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology